In focus · trending topic

biomarker discovery

1 stories · following the connections

Exosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) Inhibitor

By Nasdaq OMXMar 14, 2018, 11:30 AM UTC